sectors
Health Care
Johnson & Johnson reports medicines and medical technology alongside material adjustments to earnings. Product sales, acquisition activity and litigation charges answer different analytical questions. Coverage Johnson & Johnson (JNJ). Reading approach Read the reported-to-adjusted bridge and retain its accounting labels. Regional sales and segment sales are alternative breakdowns of the same total, not additive populations. Comparison limits This issuer case does not represent insurers or the whole health-care industry. Future guidance is separate from the quarter already reported. Sector labels are editorial research groupings for this collection, not licensed or issuer-confirmed classifications.
Medical innovation and specified charges →